StockData
APMDNasdaqPharmaceutical PreparationsFiscal year ends December 31

Apnimed, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 8, 2026
$16.59−1.17 (-6.56%)

Close on Oct 19, 2026

Market cap
$536.90M
P/E (TTM)
–
Dividend yield
–

Apnimed, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Apnimed does not break out revenue by segment, region or product in the tagged data of its filings for this period type.